United States Vaccines Market Size & Outlook, 2025-2033

United States Vaccines Market Insights

As highlighted in Reed Intelligence analysis, the United States Vaccines Market, worth USD 19803.02 Million in 2024, is forecasted to achieve USD 37541.6 Million by 2033.
The United States market is anticipated to grow at a CAGR of 7.34% during the period 2025–2033.
By 2024, Monovalent represented the largest share of the By Type market size.
Monovalent is expected to remain the key growth driver within By Type, registering the fastest CAGR during the forecast period.

Other Key Findings

United States contributed 29.3% to the global Vaccines Market size in 2024.
By 2033, United States is forecasted to remain the largest global market for Vaccines Market.
In North America, United States is projected to capture the leading share of market size by 2033.
Among North America markets, United States is expected to post the fastest growth, reaching USD 37461.55 Million by 2033.

Report Summary

Report Scope	Details
Base Year for Study	2024
Study Period	2021-2033
Historical Period	2021-2023
Forecast Period	2025-2033
Market Size In 2024	USD 19803.02 Million
Market Size In 2033	USD 37541.6 Million
Largest segment	Monovalent
Units	Revenue in USD Million
CAGR	7.34% (2025-2033)
Segmnetation Covered
By Type	Monovalent Multivalent
By Route of Administration	Oral Parenteral Nasal
By Disease Indication	Viral Bacterial
By Age Group	Pediatric Adult
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

United States Vaccines Market By Type 2025-2033 (USD Million)

By Type	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Monovalent	XX.x	XX.x	XX.x	11794.68	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Multivalent	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

United States Vaccines Market By Route of Administration 2025-2033 (USD Million)

By Route of Administration	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Oral	XX.x	XX.x	XX.x	8929.18	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Parenteral	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Nasal	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

United States Vaccines Market By Disease Indication 2025-2033 (USD Million)

By Disease Indication	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Viral	XX.x	XX.x	XX.x	11238.21	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Bacterial	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

United States Vaccines Market By Age Group 2025-2033 (USD Million)

By Age Group	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Pediatric	XX.x	XX.x	XX.x	11052.07	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Adult	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Author :

Reed Intelligence Research Team

The Reed Intelligence Research Team brings together over 15+ years of collective experience in market research, data analytics, and strategic consulting. Comprising seasoned analysts, economists, and industry specialists, the team delivers precise, data-driven insights across sectors including technology, healthcare, energy, manufacturing, and consumer goods. By combining domain expertise with modern analytical tools, they ensure each report meets the highest standards of accuracy and relevance.